About
Anthony Schwartz, Ph.D., is a biotech entrepreneur focused on longevity and genetic-disease therapeutics. University Lab Partners identified him in 2020 as CEO of Morphiex Biotherapeutics and as an instructor teaching company formation and entrepreneurship at Johns Hopkins. As of a June 4, 2026 PRNewswire release, he was CEO of ARTAN Bio, a St. Petersburg, Florida longevity biotech company developing mutation-specific codon suppression technology with decentralized-science support from VitaDAO.
Areas of interest
longevitybiotechnologygenetic medicineagingdecentralized sciencecryptostartup fundraisingentrepreneurshiponcologyanesthesia reversal